EUVIMEDEUVIMED entdecken
Open Access

Hope Against Resistance: In Vitro Activity of the Ceftazidime-Avibactam and Aztreonam Combination Against Colistin-Resistant Klebsiella pneumoniae

Munmun Mutha, Parimala Subramani, Raveesha A

Cureus · 14.06.2026

DOI: 10.7759/cureus.110850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 14.06.2026. Verfasst von Munmun Mutha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology, Sri Devaraj Urs Medical College, Kolar, IND. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(CRKP) represents a major global health threat. Rising colistin resistance in CRKP further restricts therapeutic options. With no newer antibiotics in the pipeline, the combination of ceftazidime-avibactam (CZA) and aztreonam (ATM) has emerged as a rational strategy to overcome complex β-lactamase-mediated resistance.

Aim

The aim of this study was to determine the in vitro susceptibility and synergy rates of CZA + ATM among colistin-resistant CRKP isolates.

Methods

A prospective laboratory study including 17 colistin-resistant CRKP isolates was conducted. Synergy testing was performed using the disk elution method in cation-adjusted Mueller-Hinton broth (CA-MHB), as per the latest CLSI guidelines.

Results

Notably, 12 of 17 (70.6%) isolates demonstrated synergistic susceptibility to CZA + ATM. Three isolates (17.6%) were susceptible to CZA alone, and the remaining two (11.8%) were susceptible to ATM alone.

Conclusion

CZA + ATM demonstrates remarkable in vitro efficacy against colistin-resistant CRKP and is a notable carbapenem- and colistin-sparing treatment alternative.

Schlagwörter

Stichwörter der Autor:innen

aztreonam (atm)carbapenem-resistant klebsiella pneumoniaeceftazidime-avibactamcolistin-resistant k. pneumoniaedrug synergism

Autor:innen und Institutionen

  • Microbiology, Sri Devaraj Urs Medical College, Kolar, IND.
  • General Medicine, Sri Devaraj Urs Medical College, Kolar, IND.

Zitieren

APA

Mutha, M., Subramani, P., & A, R. (2026). Hope Against Resistance: In Vitro Activity of the Ceftazidime-Avibactam and Aztreonam Combination Against Colistin-Resistant Klebsiella pneumoniae. Cureus. https://doi.org/10.7759/cureus.110850

Vancouver

Mutha M, Subramani P, A R. Hope Against Resistance: In Vitro Activity of the Ceftazidime-Avibactam and Aztreonam Combination Against Colistin-Resistant Klebsiella pneumoniae. Cureus. 2026. doi:10.7759/cureus.110850

BibTeX
@article{Mutha2026,
  author = {Mutha, Munmun and Subramani, Parimala and A, Raveesha},
  title = {Hope Against Resistance: In Vitro Activity of the Ceftazidime-Avibactam and Aztreonam Combination Against Colistin-Resistant Klebsiella pneumoniae},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.110850}
}
Kostenlos starten →